Market News AIOpen the app

CVKD stock news · Cadrenal Therapeutics

Stories about Cadrenal Therapeutics (CVKD) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for CVKD

Follow Cadrenal Therapeutics (CVKD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CVKD
Free on the App Store and Google Play, or on the web.
  1. Oct 13, 2026, 1:19 PM ET · Market

    12 health care stocks are changing a lot during Tuesday's trading.

    Neutral

    Cadrenal Therapeutics shares rose 19%, but the story gives no business update, so the move alone does not change its outlook.

  2. Oct 7, 2026, 9:27 AM ET · Market

    Cadrenal Therapeutics, Inc. says its Board is looking for ways to increase the company's value.

    Neutral

    Cadrenal is exploring ways to use or sell its assets, but no deal is promised and there is no timetable. Its outlook remains unchanged for now.

  3. Sep 29, 2026, 5:51 PM ET · Market

    Cadrenal Therapeutics, Inc. has new directors and officers after some left, along with new pay plans for them.

    Bad for CVKD

    CVKD's shareholders approved more shares for awards and up to 960,000 shares from warrants. Those permissions could expand the share count, making this filing unfavorable for current owners.